Aug 29, 2013, 05.15 PM | Source: CNBC-TV18
According to Abhijit Paul, Founder of Alphative Advisors LLP, one may book some profits in Ranbaxy Laboratories around Rs 415-420.
Abhijit Paul (more)
Founder, Alphative Advisors LLP | Capital Expertise: Equity - Technical
“We have a decent bounce back in our hands now and keeping in mind that the underline long-term trends are fairly strong, there can be a short-term long bet in names like Dr Reddy's, Lupin as well but Ranbaxy Laboratories moved quite sharply and close to that Rs 415-420 range, it has some amount of serious supply. So if one has made use of this move in the stock, this is the kind of range where one should take some profit of the table.”